AKYA Overview

Key Data

  • Open $18.39
  • Day Range 17.13 - 18.50
  • 52 Week Range 17.13 - 28.96
  • Market Cap $701.62M
  • Shares Outstanding 36.68M
  • Public Float 0
  • Beta 1.58
  • Rev. per Employee N/A
  • P/E Ratio N/A
  • EPS N/A
  • Yield N/A
  • Dividend N/A
  • Ex-Dividend Date N/A
  • Short Interest 0 04/15/21
  • % of Float Shorted N/A
  • Average Volume 343.81K

Performance

5 Day
  • -13.45%

Recent News

  • MarketWatch
  • Dow Jones

Akoya Biosciences started t buy with $25 stock price target at Canaccord Genuity

May. 11, 2021 at 10:24 a.m. ET by Tomi Kilgore

Akoya Biosciences started at overweight with $23 stock price target at J.P. Morgan

May. 11, 2021 at 7:40 a.m. ET by Tomi Kilgore
Barron's

3 Biotech Stocks Started Trading Today. What to Know About Each.

Apr. 16, 2021 at 12:48 p.m. ET by Barron's
  • Other News
  • Press Releases

No Headlines Available

Akoya Biosciences Inc.

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Menlo Park, CA.